Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

Author： Boulianne N.   De Serres G.   Duval B.   Ratnam S.   Ward B.J.   Joly J.R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.16, 1995-11, pp. : 1611-1616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

By Miller E.   Rush M.   Hill A.   Morgan-Capner P.   Forsey T.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months

By Bottiger M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1759-1762

Elsevier

Access to resources Recommend Favorite

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

By Davidkin I.   Valle M.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2052-2057

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite

Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite